CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with ankylosing spondylitis (AS).Objective: to evaluate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, T. V. Dubinina, Sh. F. Erdes
Formato: Artigo
Lenguaje:Russo
Publicado: IMA-PRESS LLC 2018-05-01
Colección:Научно-практическая ревматология
Materias:
etanercept
ankylosing spondylitis
axial spondyloarthritis
remission
Acceso en línea:https://rsp.mediar-press.net/rsp/article/view/2524
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares